PF-04991532

DRUG6 trials

Sponsors

Pfizer

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism DisordersHealthyType 2 Diabetes Mellitus

Phase 1

Single Dose Study of PF-04991532 in Healthy Subjects

CompletedNCT01102673

PfizerDiabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders

Start: 2010-04-30End: 2010-06-30Target: 18Updated: 2010-08-05

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

CompletedNCT01129258

PfizerDiabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders

Start: 2010-06-30End: 2010-12-31Updated: 2011-03-09

A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532

CompletedNCT01369277

PfizerDiabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders

Start: 2011-06-30End: 2011-09-30Updated: 2011-09-22

Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532

CompletedNCT01369602

PfizerHealthy, Type 2 Diabetes Mellitus

Start: 2011-07-31End: 2012-02-29Updated: 2012-02-22

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

CompletedNCT01469065

PfizerDiabetes Mellitus, Type 2

Start: 2011-12-31End: 2012-05-31Updated: 2013-10-30

Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532

CompletedNCT01469481

Start: 2011-11-30End: 2011-11-30Updated: 2012-01-31